JACKSONVILLE, Fla. – Aug. 5, 2015 – 21st Century Oncology is pleased to announce that Board Certified Medical Oncologist Troy H. Guthrie, Jr., M.D., joined the Jacksonville cancer treatment team as the Director of Clinical Research.
In this role, Dr. Guthrie will help enhance 21st Century Oncology's clinical research department in providing the most advanced cancer-fighting diagnostic, treatment and clinical trial services as part of a seamless continuum of care. Dr. Guthrie will also be treating patients in the UF Health Oncology LaVilla office, located at 425 North Lee Street, Suite 204 in Jacksonville.
Dr. Guthrie’s extensive research experience includes over 100 published citations in clinical journals, over 60 national and international presentations, and three book chapters.
His current research interests include clinical trials focusing on immunotherapy in all tumor sites, as well as trials with vaccines monoclonal antibodies and targeted agents.
“We are proud to have Dr. Guthrie as Director of Clinical Research to expand clinical research in the fight against cancer,” says Joseph Mignone, M.D., 21st Century Oncology of Jacksonville’s Medical Director. “His extensive research background and proven dedication to patient care make him an invaluable asset to our team."
After earning his medical degree from the Medical College of Georgia, Dr. Guthrie went on to complete his internship and residency at the University of Texas Health Science Center in San Antonio, Texas. He then completed fellowship training in hematology and oncology at Medical College of Georgia in Augusta, Georgia.
Dr. Guthrie is board certified in internal medicine and medical oncology. His focus is on quality care and clinical trials for patients with breast, lung, skin, gastrointestinal and prostate cancer, sickle cell anemia, lymphoma, melanoma, and brain tumors.
For more information about our services, visit www.21stCenturyOncology.coor call (904) 427-1200.
About 21st Century Oncology:
21st Century Oncology is the largest global, physician led provider of Integrated Cancer Care services. The company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of March 31, 2015, the company operated 182 treatment centers, including 147 centers located in 17 states and 35 centers located in six countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad.